Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

143.97
+7.355.38%
Post-market: 144.370.4018+0.28%18:39 EDT
Volume:15.39M
Turnover:2.25B
Market Cap:57.48B
PE:-17.98
High:149.73
Open:137.91
Low:135.01
Close:136.62
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:4.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.50
PE(LYR):-19.83

Loading ...

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19

Moderna Shares Extend Gains; Last up 46.9% Premarket

THOMSON REUTERS
·
Aug 19

Movement Alert|Moderna, Inc. Rises 8.74% in Pre-Market Trading, Multiple Catalysts Including Positive Melanoma Trial and Flu Vaccine Retail Launch

Market Focus
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Reuters
·
Aug 19

Moderna (MRNA) Stock Looks Pricey After A 126% Return Yet Sales Stay Strong

Simply Wall St.
·
Aug 17

Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist

Simply Wall St.
·
Aug 16

Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults

TIPRANKS
·
Aug 14

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Dow Jones
·
Aug 13

Stock Track | Moderna Soars Over 5% Intraday on First mRNA Flu Vaccine FDA Approval and Q2 Earnings Beat

Stock Track
·
Aug 13

Movement Alert|Moderna, Inc. Rises 5.17% in Regular Trading, First mRNA Flu Vaccine FDA Approval Combined with Q2 Earnings Beat

Market Focus
·
Aug 12

Stock Track | Moderna Soars 5% in Pre-Market as FDA Approval of First mRNA Flu Vaccine Continues to Drive Gains

Stock Track
·
Aug 10